Health Care & Life Sciences » Pharmaceuticals | KPC Pharmaceuticals Inc.

KPC Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own KPC Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
5,349,286
0.79%
0
0.08%
12/31/2017
Nanfang CSI 500 ETF
2,373,578
0.35%
-111,300
0.12%
12/31/2017
1,573,556
0.23%
25,000
0.79%
12/31/2017
1,293,232
0.19%
0
0.12%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
803,396
0.12%
0
0%
07/31/2018
334,918
0.05%
31,900
0.26%
12/31/2017
319,035
0.05%
-78,500
0.31%
12/31/2017
243,300
0.04%
243,300
0.16%
12/31/2017
GF CSI 500 ETF
186,444
0.03%
-45,620
0.13%
12/31/2017
165,000
0.02%
17,200
0.76%
12/31/2017

About KPC Pharmaceuticals

View Profile
Address
No. 166 Keyi Road
Kunming Yunnan 650106
China
Employees -
Website http://www.kpc.com.cn
Updated 07/08/2019
KPC Pharmaceuticals, Inc. engages in the research and development, manufacture, sale, commercial wholesale, and international marketing of drugs. It focuses on natural herbal-based Chinese medicine, chemical medicine, and pharmaceutical area. Its products include panax notoginseng, gastrodine, artemether, and special botanical drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.